Navigation Links
Vaccines and autism: Many hypotheses, but no correlation
Date:1/30/2009

An extensive new review summarizes the many studies refuting the claim of a link between vaccines and autism. The review, in the February 15, 2009 issue of Clinical Infectious Diseases and now available online, looks at the three main hypotheses and shows how epidemiological and biological studies refute these claims.

"When one hypothesis of how vaccines cause autism is refuted, another invariably springs up to take its place," said study author Paul Offit, MD, of the Children's Hospital of Philadelphia. Fears about vaccines are pushing down immunization rates and having a real impact on public health, he added. Vaccine refusal is contributing to the current increase in Haemophilus influenzae cases in Minnesotaincluding the death of one childand was a factor in last year's measles outbreak in California.

The controversy began with a 1998 study in The Lancet that suggested a link between the combination measles-mumps-rubella (MMR) vaccine and autism. Dr. Offit and co-author Jeffrey Gerber, MD, PhD, also of the Children's Hospital of Philadelphia, reviewed more than a dozen large studies, conducted in five different countries, that used different methods to address the issue, and concluded that no data supported the association between the MMR vaccine and autism. The correlation between MMR vaccine and the appearance of autism symptoms is merely coincidental, the authors say, because the MMR vaccine is given at the age when autism symptoms usually appear.

Also hypothesized as a cause has been the ethylmercury-containing preservative thimerosal, which was used in vaccines for over 50 years. However, the authors review seven studies from five countries that show that the presence or absence of thimerosal in vaccines did not affect autism rates.

The third suggestion has been that the simultaneous administration of multiple vaccines overwhelms or weakens the immune system. The authors explain that children's immune systems routinely handle much more than the relatively small amount of material contained in vaccines. Furthermore, today's vaccines contain many fewer immune-triggering components than those from decades past. Regardless, autism is not triggered by an immune response, the authors say.

With outbreaks of vaccine-preventable diseases on the rise due to some worried parents choosing not to vaccinate their children, Dr. Offit said, "Parents should realize that a choice not to get a vaccine is not a risk-free choice. It's just a choice to take a different, and far more serious, risk."


'/>"/>

Contact: Steve Baragona
sbaragona@idsociety.org
703-299-0412
Infectious Diseases Society of America
Source:Eurekalert

Related biology news :

1. New type of vaccines deliver stronger and faster immune response
2. Syracuse University partners with Serum Institute of India to develop vaccines for children
3. Prostate cancer vaccines more effective with hormone therapy
4. From foe to friend: Researchers use salmonella as a way to administer vaccines in the body
5. VaxInnate to discuss seasonal and pandemic flu vaccines during BIO 2008 this week
6. Iowa State researchers look for smaller, cheaper, 1-dose vaccines
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2016)... 2016   EyeLock LLC , a market leader ... of an IoT Center of Excellence in ... development of embedded iris biometric applications. EyeLock,s ... and security with unmatched biometric accuracy, making it the ... DNA. EyeLock,s platform uses video technology to deliver a ...
(Date:5/9/2016)... 9, 2016 Elevay is currently ... expanding freedom for high net worth professionals seeking travel ... globally connected world, there is still no substitute for ... duplicate sealing your deal with a firm handshake. This ... taking advantage of citizenship via investment programs like those ...
(Date:4/28/2016)... BANGALORE, India , April 28, 2016 ... of Infosys (NYSE: INFY ), and Samsung SDS, ... partnership that will provide end customers with a more ... payment services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) ... financial services, but it also plays a fundamental part in ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... (PRWEB) , ... June 27, 2016 , ... Parallel ... clinical trials, announced today the Clinical Reach Virtual Patient Encounter CONSULT module ... circle with the physician and clinical trial team. , Using the CONSULT module, patients ...
(Date:6/27/2016)... June 27, 2016  Liquid Biotech ... funding of a Sponsored Research Agreement with The ... cells (CTCs) from cancer patients.  The funding will ... levels correlate with clinical outcomes in cancer patients ... will then be employed to support the design ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
Breaking Biology Technology: